Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3–TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3–TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study
Authors
Keywords
Diabetes mellitus, Drug therapy, Glucose metabolism, Inflammation, Insulin secretion, Low-dose pioglitazone, Muscle biopsy, TACE (TNF-α converting enzyme), TIMP-3 (Tissue inhibitor of metalloproteases 3)
Journal
DIABETOLOGIA
Volume 56, Issue 10, Pages 2153-2163
Publisher
Springer Nature
Online
2013-06-29
DOI
10.1007/s00125-013-2976-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Effects of Salsalate on Glycemic Control in Patients With Type 2 Diabetes
- (2013) Allison B. Goldfine ANNALS OF INTERNAL MEDICINE
- Muscles, exercise and obesity: skeletal muscle as a secretory organ
- (2012) Bente K. Pedersen et al. Nature Reviews Endocrinology
- CD14 Modulates Inflammation-Driven Insulin Resistance
- (2011) J. M. Fernandez-Real et al. DIABETES
- Fractalkine: A Cellular Link Between Adipose Tissue Inflammation and Vascular Pathologies
- (2011) W. T. Cefalu DIABETES
- Visceral abdominal adipose tissue and coronary atherosclerosis in asymptomatic diabetics
- (2011) Alla Khashper et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
- (2011) Ralph A. DeFronzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thiazolidinedione Drugs and Cardiovascular Risks
- (2010) Sanjay Kaul et al. CIRCULATION
- Adipocytokines in Atherothrombosis: Focus on Platelets and Vascular Smooth Muscle Cells
- (2010) Giovanni Anfossi et al. MEDIATORS OF INFLAMMATION
- Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005
- (2009) Sarah Rosner Preis et al. CIRCULATION
- Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes
- (2009) Yoshimasa Aso et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Impaired regulation of the TNF-α converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans
- (2009) A. Monroy et al. DIABETOLOGIA
- Comparative Study of Low-dose Pioglitazone or Metformin Treatment in Japanese Diabetic Patients with Metabolic Syndrome
- (2009) T. Kato et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Rosiglitazone activation of PPARγ suppresses fractalkine signaling
- (2009) Yihong Wan et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- siRNA-Mediated Reduction of Inhibitor of Nuclear Factor- B Kinase Prevents Tumor Necrosis Factor- -Induced Insulin Resistance in Human Skeletal Muscle
- (2008) R. L. Austin et al. DIABETES
- Fractalkine Deficiency Markedly Reduces Macrophage Accumulation and Atherosclerotic Lesion Formation in CCR2 −/− Mice
- (2007) Noah Saederup et al. CIRCULATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started